Skip to content

Low Concentration ALA-PDT in Treatment of Skin Ulcer

Clinical Study of Low Concentration ALA-PDT in Treatment of Skin Ulcer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04689243
Enrollment
28
Registered
2020-12-30
Start date
2019-01-01
Completion date
2020-12-30
Last updated
2020-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Ulcer, Photodynamic Therapy

Brief summary

Skin ulcer is a common disease with complicated etiopathogenes, which makes it hard to be cured. It has been reported that photodynamic therapy (PDT) can be used to treat skin ulcers which were caused by different diseases. However, PDT is an expensive treatment and patients always experience obvious pain during or after the treatment, which hinders the application of PDT in skin ulcer. Our previous study found that PDT using a low concentration of 5-Aminolevulinic acid (ALA) could promote the healing of skin ulcer without obvious adverse reactions, which suggests us that low concentration ALA-PDT might be an efficient and cost effective treatment in skin ulcer. To further investigate the use of low concentration ALA-PDT in skin ulcer, we plan to recruit patients with skin ulcers caused by different diseases, and divide these patients into different groups according to their causes of disease, and then treat them using low concentration ALA-PDT to observe the healing process of skin ulcer. This study could further optimize and promote the use of low concentration ALA-PDT in skin ulcer.

Interventions

PROCEDUREALA-PDT

Low concentration ALA-PDT, 3 times a week.

PROCEDUREred light

red light, 3 times a week.

Sponsors

Sichuan Provincial People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* chronic skin wounds that involved the dermis and did not heal in three months or did not exhibit a tendency toward healing

Exclusion criteria

* allergies to photosensitizers and their solvents, serious medical illnesses, such as severe heart disease, severe liver or kidney dysfunction, systemic infection or any concomitant infection that would require treatment with an additional antimicrobial agent, the use of topical or systemic antibiotics within one month prior to treatment. Pregnant or lactating women were also excluded.

Design outcomes

Primary

MeasureTime frameDescription
ulcer area sizeChange from Baseline ulcer area size at 24 hours after the last treatment.The ulcer area size was measured

Secondary

MeasureTime frameDescription
total bacterial loadChange from Baseline total bacterial load at 24 hours after the last treatment.Levels of total bacteria were tested

Countries

China

Contacts

Primary ContactYujie Mao, M.D.
yujiemao@yeah.net(86)02887393999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026